Cough Syrup Market Size 2023-2028, Share, Segment, Business SWOT Analysis and Revenue Forecast | Acella Pharmaceuticals LLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson and More
IMARC Group has recently released a new research study titled " Cough Syrup Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028 ", offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios. How big is the cough syrup market? The global cough syrup market size reached US$ 5.7 Billion in 2022 . Looking forward, IMARC Group expects the market to reach US$ 7.3 Billion by 2028, exhibiting a growth rate (CAGR) of 4.11% during 2023-2028. Cough Syrup Market Report 2023-2028 Market Outlook: Cough syrup is a combination drug that offers temporary relief from common cold, cough, hay fever, and other respiratory allergies. It is produced using expectorants, non-opioid cough suppressants, and antihistamine compounds to block the symptoms. The suppressants help alleviate the symptoms of dry cough by reducing the activity of the cough reflex an...